- 工作地点：上海
- 职位：医药代表（应届毕业生）
- 信息来源：前程无忧
说明：
此信息由前程无忧审核并发布（查看原发布网址），应届生求职网转载该信息只是出于传递更多就业招聘信息，促进大学生就业的目的。如您对此转载信息有疑义，请与原信息发布者前程无忧核实，并请同时联系本站处理该转载信息。
工作内容：
1.负责公司产品在目标区域内的推广，传递公司产品信息，并达成公司的销售目标
2.负责目标区域内客户的管理，包括建立及更新客户资料，维护客户关系等工作、并合理使用公司资源。
3.完成公司规定的各类销售报表
4.收集区域内竞争对手的信息
5.严格遵守公司的商业行为规范政策，有效地执行公司的市场计划
资质要求：
1.2009年应届全日制本科毕业生或研究生 （医学，药学等）
2.热爱销售行业
3.良好的沟通能力和学习能力
4.有责任心和团队合作精神
5.勇于接受挑战、承受压力
6.具备良好的英文沟通能力（CET-4级以上）
7.能熟练使用Word/Excel/Powerpoint
公司简要介绍：
Headquartered in Brussels (Belgium), UCB (ww***com[点击查看]) is a leading global biopharmaceutical company dedicated to the research, development and commercialisation of innovative pharmaceutical and biotechnology products in the fields of central nervous system disorders, allergy/respiratory diseases, immune and inflammatory disorders and oncology - UCB focuses on securing a leading position in severe disease categories. The company combines passion for innovation with a mission to provide therapeutic solutions for patients with severe diseases treated by specialists. Employing more than 8,400 people in over 40 countries, UCB achieved revenues of 2.5 billion euro in 2006. UCB is listed on the Euronext Brussels Exchange.
UCB China’s business started in 1995. Zyrtec is widely prescribed in China to treat allergy patients. Keppra, recently launched in China in 2007, is one of the top products for UCB and is a new treatment for epilepsy that has already been successfully commercialized in several countries. The revenue for Keppra in 2006 was 761 million euro (growth of 36% as compared to 2005). Today, Keppra is the most successful new treatment for epilepsy in the USA. As UCB is to expand quickly in China and with the launch of new products in the fields of Allergy and Central Nervous System (CNS), we are inviting high-caliber individuals to join UCB China.
全球领先的生物制药企业--比利时优时比制药公司（UCB）始建于1928年，总部设在比利时布鲁塞尔，在八十年的发展中，致力于为重症患者提供更多的创新治疗方法。
优时比制药在华机构包括优时比贸易（上海）有限公司和珠海许瓦兹制药有限公司，业务遍及全国，产品涉及中枢神经系统疾病、变应性疾病、心血管疾病、贫血和疼痛治疗等领域。由于公司在中国业务高速发展的需要，我们诚邀各路人才加入，与我们在中国一同成长。
To apply, please send resumes in English and Chinese with details of qualifications, experience, current and expected salary, together with a recent photograph to:
地址：上海市西藏中路268号2802室
优时比贸易（上海）有限公司 人力资源部 收 邮编：200001
E-mail: ucbcn.hr@
请务必在电子邮件的主题和信封的左下角注明所应聘的职位。如无面试通知，来电来访恕不接待。
UCB China’s business started in 1995. Zyrtec is widely prescribed in China to treat allergy patients. Keppra, recently launched in China in 2007, is one of the top products for UCB and is a new treatment for epilepsy that has already been successfully commercialized in several countries. The revenue for Keppra in 2006 was 761 million euro (growth of 36% as compared to 2005). Today, Keppra is the most successful new treatment for epilepsy in the USA. As UCB is to expand quickly in China and with the launch of new products in the fields of Allergy and Central Nervous System (CNS), we are inviting high-caliber individuals to join UCB China.
全球领先的生物制药企业--比利时优时比制药公司（UCB）始建于1928年，总部设在比利时布鲁塞尔，在八十年的发展中，致力于为重症患者提供更多的创新治疗方法。
优时比制药在华机构包括优时比贸易（上海）有限公司和珠海许瓦兹制药有限公司，业务遍及全国，产品涉及中枢神经系统疾病、变应性疾病、心血管疾病、贫血和疼痛治疗等领域。由于公司在中国业务高速发展的需要，我们诚邀各路人才加入，与我们在中国一同成长。
To apply, please send resumes in English and Chinese with details of qualifications, experience, current and expected salary, together with a recent photograph to:
地址：上海市西藏中路268号2802室
优时比贸易（上海）有限公司 人力资源部 收 邮编：200001
E-mail: ucbcn.hr@
请务必在电子邮件的主题和信封的左下角注明所应聘的职位。如无面试通知，来电来访恕不接待。
获致幸福的不二法门是珍视你所拥有的、遗忘你所没有的。 download.yingjiesheng.com
